Sept. 17, 2003 -- Fixed dose rate (FDR) infusion of gemcitabine improved survival of patients with pancreatic cancer compared with the standard dose-intense protocol, according to the results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results